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Background: Malaria is the major parasitic disease worldwide caused by Plasmodium infection. The objective of
integrated malaria control programs is to decrease malaria transmission, which needs specific tools to be accurately
assessed. In areas where the transmission is low or has been substantially reduced, new complementary tools have
to be developed to improve surveillance. A recent approach, based on the human antibody response to Anopheles
salivary proteins, has been shown to be efficient in evaluating human exposure to Anopheles bites. The aim of the
present study was to identify new An. gambiae salivary proteins as potential candidate biomarkers of human
exposure to P. falciparum-infective bites.
Methods: Experimental infections of An. gambiae by wild P. falciparum were carried out in semi-field conditions.
Then a proteomic approach, combining 2D-DIGE and mass spectrometry, was used to identify the overexpressed
salivary proteins in infected salivary glands compared to uninfected An. gambiae controls. Subsequently, a peptide
design of each potential candidate was performed in silico and their antigenicity was tested by an epitope-mapping
technique using blood from individuals exposed to Anopheles bites.
Results: Five salivary proteins (gSG6, gSG1b, TRIO, SG5 and long form D7) were overexpressed in the infected salivary
glands. Eighteen peptides were designed from these proteins and were found antigenic in children exposed to the
Anopheles bites. Moreover, the results showed that the presence of wild P. falciparum in salivary glands modulates the
expression of several salivary proteins and also appeared to induce post-translational modifications.
Conclusions: This study is, to our knowledge, the first that compares the sialome of An. gambiae both infected and
not infected by wild P. falciparum, making it possible to mimic the natural conditions of infection. This is a first step
toward a better understanding of the close interactions between the parasite and the salivary gland of mosquitoes. In
addition, these results open the way to define biomarkers of infective bites of Anopheles, which could, in the future,
improve the estimation of malaria transmission and the evaluation of malaria vector control tools.
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In Sub-Saharan Africa, Anopheles gambiae is the main
vector of Plasmodium falciparum, the most deadly of
the five human Plasmodium species, responsible for
malaria. Over half a million deaths (627,000) occur every
year, especially in children under 5 years of age, accord-
ing to WHO [1]. Due to the lack of vaccines, the spread
of resistance to anti-malaria drugs [2] and the difficulty
in accessing drug treatment (the artemisinin-based com-
bination therapies), vector control using Long Lasting
Insecticide-treated Nets (LLIN) and/or Indoor Residual
Spraying (IRS) still remains an important component of
malaria prevention and control. However, the develop-
ment of insecticide resistance in the main malaria vec-
tors in Africa [3] is challenging the success of malaria
vector control strategies [4,5]. In a context of malaria
elimination in some areas, integrated malaria control
campaigns have been implemented to reduce the malaria
burden. Consequently, in these areas where transmission
has substantially decreased, but also in urban settings or
high-altitude areas where Anopheles exposure and mal-
aria transmission can be very low, the current methods
are not sufficiently sensitive to evaluate the human ex-
posure to Anopheles bites and the risk of transmission.
Indeed it appears difficult to obtain precise information
on parasite detection and mosquito capture in these
contexts so the development of appropriate tools is
necessary.
One promising approach is to evaluate the real contact
between the human host and the vector by measuring
the human antibody (Ab) response to specific Anopheles
salivary proteins [6]. During its blood meal, mosquitoes
inject saliva into the human skin, inducing a humoral
response. This concept has been validated using whole
saliva extracts (WSEs) of An. gambiae [6] and in other
hematophagous arthropods, such as Aedes [7-9], Culex
[10,11], Glossina [12,13] and phlebotomine sand flies
[14,15]. However, some salivary proteins are ubiquitous
in arthropods and the response observed against WSEs
could therefore reflect the exposure to numerous arthro-
pods. For this reason, a biomarker of human exposure
to bites must be directed to genus- or species-specific
epitopes. Based on previous studies, the gSG6 protein
has been shown to be specific to the Anopheles genus
and immunogenic [16,17]. This protein was therefore
validated as a specific biomarker of exposure to Anoph-
eles bites in Burkina Faso [18,19] and Tanzania [20].
To optimize the specificity and the utility of the bio-
marker, a peptide design of this protein was performed.
The gSG6-P1 peptide has been found to be antigenic
and the Ab response to this peptide was positively asso-
ciated with the level of exposure to Anopheles bites [21].
This peptide has also been validated as a biomarker in
different malaria transmission areas such as rural lowexposure in Senegal [22,23], in highland areas in Kenya
[24], in urban settings [25] and for exposure to An.
funestus [26]. The limitation of this biomarker is that the
Ab response to the gSG6 protein and the gSG6-P1 pep-
tide may not discriminate between infective and non-
infective bites, hence limiting the estimation of malaria
transmission intensity. Settings of malaria transmission
could be very different depending on field conditions,
from unstable to stable malaria, with sporozoite rates
ranging from 0.1% to 8% [27,28]. In low-transmission
areas, the exposure to all Anopheles bites does not ac-
curately represent the malaria transmission risk [29].
Moreover, hotspots of malaria transmission exist in all
epidemiological settings, maintaining transmission in low-
transmission seasons and fueling transmission in high-
transmission seasons; the detection of these hotspots will
make it possible to concentrate the integrated malaria
controls [30]. Consequently, a new biomarker specific to
infective bites has to be developed to assess precisely mal-
aria risk in these particular settings and could also be use-
ful for evaluating the efficacy of malaria control tools
(drug treatments and vector controls).
The salivary glands are the crucial organ for the devel-
opment and transmission of the parasite to a host.
Plasmodium interacts with salivary proteins to enter saliv-
ary glands [31-34]. To survive and multiply in this organ,
parasites have to counteract the immune system and use
the vector’s metabolism by modifying salivary protein ex-
pression [35]. Saliva is also essential for the success of
blood-feeding [36], and consequently, the modification of
salivary protein expression could promote parasite devel-
opment and transmission. Rossignol et al., have demon-
strated for the first time that the Plasmodium infection in
mosquitoes decreased the expression of a salivary protein,
the apyrase enzyme [37]. Transcriptomic studies have
shown that genes encoding for salivary proteins were up-
or down-regulated in Ixodes scapularis nymphs infected
by flavivirus [38], Rhipicephalus microplus infected by
Anaplasma marginale [39], Culex quinquefasciatus in-
fected by West Nile virus [40] and Aedes aegypti infected
by different serotypes of dengue virus (DENV) [41]. Prote-
omic analyses have indicated that salivary proteins were
modulated in Glossina pallipides infected by salivary gland
hypertrophy virus [42], Ae. aegypti infected by DENV
serotype 2 (DENV-2) [43], Ae. albopictus infected by
DENV-2 [44] and Ae. aegypti infected by chikungunya
virus (CHIKV) [45]. As for Plasmodium parasites, several
studies have investigated the change of salivary protein ex-
pression in An. gambiae and An. stephensi infected by
murine Plasmodium [46-49]. The iTRAq technique, used
by Choumet et al., showed that the expression of five
salivary proteins was modulated, with the ratio between
infected versus non-infected salivary gland varying
from 0.65 to 1.97 [46]. In a more recent study using
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with a modulated expression in the presence of Plasmo-
dium berghei varying from 0.28 to 12 [47]. The present
study aimed to identify salivary proteins as potential bio-
markers of An. gambiae infective bites. To mimic field
conditions and thereby evaluate salivary protein modula-
tion as accurately as possible, experiments were conducted
in semi-field conditions. An. gambiae mosquitoes were fed
through membrane on blood containing P. falciparum ga-
metocytes from naturally infected donors. Comparison of
sialome in P. falciparum-infected versus non-infected saliv-
ary glands of An. gambiae was achieved by 2D-Differential
Gel Electrophoresis (2D-DIGE) and mass spectrometry
(LC-MS/MS). Peptides were designed from protein
candidates and their immunogenicity was tested in sera
from humans living in malaria areas. These methods
allowed us to select immunogenic peptides which could
represent potential candidate biomarkers of An. gam-
biae infective bites.
Methods
Ethics statements
Experimental infections involving human subjects were
approved by the Cameroonian National Ethical Committee
(statement 099/CNE/SE/09). Children identified as gam-
etocyte carriers were enrolled as volunteers after their par-
ents or legal guardians had signed an informed consent
form. Collection of human blood on filter papers was ap-
proved by the National Ethics Committee of the Senegal
Ministry of Health (October 2008; 0084/MSP/DS/CNRS,
ClinicalTrials.gov ID: NCT01545115). Oral and written in-
formed consent was obtained from the children’s parents
or legal guardians.
Mosquito strain
The Kisumu strain of An. gambiae mosquitoes was reared
in the insectary at the OCEAC (Yaounde, Cameroon).
Adult mosquitoes were maintained in controlled condi-
tions (27 ± 2°C, 85 ± 5% RH, and 12 h light/dark) and pro-
vided with a 6% sterile sucrose solution.
Experimental infections
Female mosquitoes were fed on P. falciparum gameto-
cyte carriers. Infectious feeding was conducted as previ-
ously described [50,51]. Females, 3–5 days old, were
starved for 24 h and allowed to feed on blood containing
P. falciparum gametocytes (from 52.7 to 60.6 gameto-
cytes/μL) for 35 min. Non-infected salivary glands were
obtained by feeding female mosquitoes on the blood
from the same donors but heated at 43°C for 12 min for
gametocyte inactivation [52]. Unfed and partially fed
mosquitoes were removed by aspiration and discarded.
Fully engorged females were kept in the insectary until
dissections 14 days after the infectious blood meal.Salivary glands were dissected in buffer containing Urea,
7M; Thiourea, 2M; CHAPS, 4%. Samples were frozen in-
dividually until processing.
Protein sample preparation
Infected and non-infected salivary glands were lysed in
liquid nitrogen and homogenates were then centrifuged
for 20 min at 30,000 × g at 17°C. The supernatants, called
salivary gland extracts (SGEs), were collected, purified
using a 2D Cleanup Kit (GE Healthcare) and protein
concentrations were measured using a Coomassie Plus
Protein kit (Pierce). SGEs from about 75 salivary glands
were pooled to obtain 15 μg of protein for each batch.
2D Differential Gel Electrophoresis (2D-DIGE)
P. falciparum-infected and non-infected protein samples
were compared using the CyDye DIGE Fluors for Ettan
DIGE (GE Healthcare, Germany) for four gel replicates.
15 μg of SGE from P. falciparum-infected and non-
infected samples was labeled with 150 pmol/μL of either
Cy3 or Cy5 following the manufacturer’s recommenda-
tions. An internal standard comprising 7.5 μg of each
SGE was labeled with Cy2. A dye swap was performed
to ensure that the modifications observed between the
two conditions were not due to different efficiencies in
dye labeling. IEF was performed with 11 cm Immobiline
DryStrip, pH 3–11 nonlinear (NL) (GE Healthcare,
Germany). The run conditions were: current 50 μA per
strip; 60 V (step) for 1 h, 1000 V (gradient) for 2 h, 6000
V (gradient) for 2 h and then 6000 V steps up to 30,000
Vh. The second dimension was carried out on 10–20%
SDS-PAGE gels (Biorad, Marnes-la-Coquette, France) at
30 V for 20 min and then 200 V until the bromophenol
blue front had reached the bottom of the gel. Gels were
scanned using a Typhoon 9400 imager (GE Healthcare,
Germany). Images were acquired at 100 μm pixel reso-
lution under non-saturating conditions and were ana-
lyzed with Progenesis Samespots 3.3 software. Statistical
analysis and protein quantification were performed with
ANOVA test (p < 0.005), which took into account the
mean difference and the variance between the infected
and non-infected groups. The fold change with a cut-off
of 1.4-fold over- and under-expression was used. The
statistical power of this study was greater than 0.9.
Protein identification by LC-MS/MS
For the spot excision, gels were stained with the PageBlue
Protein Staining Solution (Fermentas).
Trypsin digestion
Enzymatic in-gel digestion was performed according to
the Shevchenko modified protocol [53]. Briefly, gel slices
were destained by three washes in 50% acetonitrile, 50
mM triethylammonium bicarbonate buffer and incubated
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(Gold, Promega, Charbonnières, France) in 100 mM
triethylammonium bicarbonate buffer. Tryptic peptides
were extracted with 50% acetonitrile and 5% formic acid,
and dehydrated in a vacuum centrifuge.
Nano LC-MS/MS analysis
Peptides were solubilized in 2 μL of 0.1% formic acid -
2% acetonitrile and analyzed online by nano-flow HPLC-
nanoelectrospray ionization using a LTQ Orbitrap XL
mass spectrometer (LTQ Orbitrap XL, Thermo Fisher
Scientific, San Jose, CA, USA) coupled with an Ultimate
3000 HPLC (Dionex). Desalting and pre-concentration
of samples were performed on-line on a Pepmap® pre-
column (0.3 mm × 10 mm). A gradient consisting of 0-
40% B for 30 min, 80% B for 15 min (A = 0.1% formic
acid, 2% acetonitrile in water; B = 0.1% formic acid in
acetonitrile) at 300 nL/min was used to elute peptides
from the capillary (0.075 mm × 150 mm) reverse-phase
column (Pepmap®, Dionex) fitted with an uncoated silica
PicoTip Emitter (New Ojective, Woburn, MA, USA).
LC-MS/MS experiments comprised cycles of five events;
an MS1 scan with Orbitrap mass analysis at 60,000 reso-
lutions followed by collision induced dissociation (CID)
of the five most abundant precursors. Fragment ions
generated by CID were detected at the linear trap. Nor-
malized collision energy of 35 eV and activation time of
30 ms were used for CID. All Spectra were recorded
under positive ion mode using the Xcalibur 2.0.7 soft-
ware (Thermo Fisher Scientific). Spectra were acquired
with the instrument operating in the information-
dependent acquisition mode throughout the HPLC gra-
dient. The mass scanning range was m/z 400–2000 and
standard mass spectrometric conditions for all experi-
ments were: spray voltage, 2.2 kV; no sheath and auxiliary
gas flow; heated capillary temperature, 200°C; capillary
voltage, 40 V and tube lens, 120 V. For all full-scan mea-
surements with the Orbitrap detector, a lock-mass ion
from ambient air (m/z 445.120024) was used as an in-
ternal calibrant as described [54].
All MS/MS spectra were searched for against the Insecta
entries of either SwissProt or TrEMBL databases (http://
www.uniprot.org/; v 2012_07) using the Proteome Dis-
cover software v 1.3 (Thermo Fisher Scientific) and Mas-
cot v 2.3 algorithm (http://www.matrixscience.com/) with
trypsin enzyme specificity and one trypsin missed cleav-
age. Carbamidomethylation was set as fixed cystein modi-
fication and oxidation was set as variable methionine
modification for searches. A peptide mass tolerance or 5
ppm and a fragment mass tolerance of 0.5 Da were
allowed for identification.
Management and validation of mass spectrometry data
were carried out using Proteome Discoverer software v
1.3 (p < 0.01 for 2 peptides or more/protein).Peptide design
The design of potential immunogenic peptides was investi-
gated using an in silico approach. The putative B-cell epi-
topes were identified with the BcePred [55], ABCpred [56],
BepiPred [57] and SVMTrip databases [58]. The sequences
were aligned with the Blastp program in the Vectorbase
database [59] and the UniProtKB database to compare the
peptide sequences with known genomes or EST libraries.
The peptides were selected when at least three to four al-
gorithms predicted the same epitopes.
Peptide array
Experiments were performed with EpiFlag® methodology
(Innobiochips, Lille, France). Eighteen peptides of 18–27
amino acids were synthesized by solid-phase peptide syn-
thesis with an automated peptide synthesizer (Intavis AG,
Köln, Germany) using the Fmoc/tert-butyl strategy on a
20 μmol scale on a Rink-ChemMatrix® (PCAS BioMatrix
Inc, Saint-Jean-sur-Richelieu, Quebec, Canada) resin. Fol-
lowing their elongation, peptides were deprotected and
cleaved for 3 h at room temperature (RT) using TFA/
water/triisopropylsilane/EDT (1850 μL/50 μL/50 μL/50 μL),
precipitated in diethyl ether/n-heptane, 1/1 v/v, purified
by RP-HPLC on a 120-Å, 5 μm C18 Nucleosil column
using a linear water/acetonitrile gradient containing 0.05%
TFA by volume (6 mL/min, detection at 215 nm) and
lyophilized.
Each peptide characterized by RP-HPLC and MALDI-
TOF MS, was dissolved to a final concentration of 0.1
mM in 0.01 M PBS, pH 7.4, and printed on amine-
modified glass slides (Arrayit, Sunnyvale, CA, USA) in
duplicate.
Peptide arrays were blocked for 1 h at RT with PBS-M
(0.01 M PBS, pH7.4, 0.05% Tween 20 and 2.5% non-fat
milk). Saturated microarrays were washed with PBS con-
taining 0.05% Tween 20. Human sera from Senegalese
children infected by P. falciparum or not and exposed to
Anopheles bites, were diluted 1:10 in PBS-M and incu-
bated overnight at 4°C. Microarrays were then washed
three times with PBS containing 0.05% Tween 20. After
washing, the microarrays were revealed using a Alexa-
Fluor 555-labeled goat polyclonal anti-human IgG anti-
body (Life Technology, Saint Aubin, France) at 1 μg/mL
in PBS-M, for 1 h at RT. Microarrays were washed,
rinsed with distilled water and dried. The glass slides
were scanned with a TECAN LS-reloaded scanner
(Tecan, Männedorf, Switzerland): PMT = 150. Data were
extracted using Array-Pro® Analyzer Software.
Results and discussion
Difference in sialome profile between P. falciparum-
infected and non-infected salivary glands of An. gambiae
The salivary glands were dissected 14 days post-infection,
i.e. the time period needed for the parasites to reach the
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salivary glands was checked by quantitative PCR [60]. The
differential expression of the sialome between P. falcip-
arum-infected and non-infected salivary glands of An.
gambiae was assessed using 2D-DIGE. Overall, four bio-
logical replicates of gel were performed. After the ANOVA
analysis and adjustment using the FDR approach, 207
spots showed a significant differential profile (q < 0.01 and
power >0.9) with a modulation from 1.3- to 8.8-fold.
Among them, 128 spots were over-expressed and 79
under-expressed. After colloidal Coomassie blue staining,
43 visible spots could be excised for LC-MS/MS identifica-
tion (Figure 1A), which represent less than one third of
the regulated spots and constitute an additional constraint
to the identification of relevant biomarkers. Among them,
24 spots presented a 1.4- to 2.3-fold over-expression in P.
falciparum-infected salivary glands, whereas 19 spots pre-
sented a 1.4- to 2.6-fold under-expression (Figure 1B).
These fold changes were in accordance with another study
comparing the modification of the An. gambiae sialome
infected by P. berghei using the iTRAQ technology, in
which the modulations are within the same range (from
1.5 to 1.95). However, in this previous study, the expres-
sion of only five proteins was found to be altered [46]. An-
other study using the An. gambiae-P. berghei experimental
model has shown that the expression of seven salivary
proteins was changed from 3.5- to 12-fold with the 2D-
PAGE technique [47]. The larger number of differentially
expressed spots in the present experiment may be due to
broader protein regulation upon P. falciparum infection
or alternatively to the different techniques and protocols
used between studies.Figure 1 Differential salivary protein expression of An. gambiae infected
differentially expressed spots, and the only spots which have been excised, ar
and the 19 blue circles represent the under-expressed spots. Proteins were se
between pH 3 and pH 11. The second dimension was separated using on 10–
scales are indicated in the figure. (B) Differences of protein expression are rep
significance ratio (q value). The horizontal dotted line indicates the significancIdentification of overexpressed proteins in P. falciparum-
infected An. gambiae salivary glands
Among the 43 overexpressed spots, two proteins, the ubi-
quinol cytochrome c reductase iron-sulfur subunit and the
gSG6 were found and identified, each in a single spot, as a
unique protein (Figure 2 and Table 1).
The ubiquinol-cytochrome c reductase iron-sulfur sub-
unit (Rieske subunit) is an essential component of com-
plex III implicated in the oxidative phosphorylation. The
increase in the expression of this enzyme involved in the
oxidative phosphorylation has already been observed in
the head of An. gambiae infected by P. berghei [61]. The
presence of P. falciparum in An. gambiae could thus in-
crease oxidative metabolism, which could be a response
involved in parasite resistance.
The gSG6 protein was first identified in An. gambiae
[62] but also found in An. stephensi [16] and An. funestus
[63] and is specifically expressed in salivary glands in fe-
male mosquitoes [64]. This protein has not been found in
Culex [65] and Aedes [66,67] mosquitoes, suggesting that
it is specific to Anophelinae mosquitoes. A study has dem-
onstrated that this protein plays a role in blood feeding
[68]. In the present study, the infection of salivary glands
of An. gambiae by wild P. falciparum induced over-
expression of the gSG6 protein (+1.8-fold). However, other
proteomic studies in murine models of malaria have
shown that the gSG6 protein was down-regulated in An.
gambiae infected by P. berghei [46,47]. Discrepancies
between studies may result from exposure to different
strains of parasites. It is known that a strong relationship
between pathogens and their hosts exists, which generates
mutual co-evolution and co-adaptation [52,69,70]. In ouror not infected by wild P. falciparum. (A) 2D-DIGE gel. Forty-three
e indicated by circles. Red circles represent the 24 over-expressed spots
parated in the first dimension using carrier ampholyte gradient gels
20% SDS-PAGE gels. The isoelectric point (pI) and molecular weight
resented according to the expression ratio (infected/non-infected) and
e threshold of q < 0.05 (or 1/q > 20) according to the Samespot analysis.
Figure 2 Overexpressed proteins in P. falciparum-infected An. gambiae salivary glands (2D-DIGE gel). Over-expressed protein spots are
indicated by number. The pI and molecular weight scales are indicated in the figure.
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gambiae and P. falciparum, whereas in the other studies
An. gambiae was infected by a rodent malaria parasite P.
berghei, whose natural mosquito vector is An. dureni [71].
In addition, we used natural isolates of P. falciparum and
parasite transmission efficiency relies on multiple factors,
such as density, sex ratio or genetic complexity [52,72-74].
Interestingly, gene regulation upon P. falciparum infection
in the mosquito midgut is infection intensity-dependent
[52]. In the present study, the gametocyte loads in infected
individuals ranged from 52.7 to 60.6 gametocytes/μL of
blood, which is low compared to parasite densities used
with P. berghei in laboratory conditions. Differences in
parasite densities within salivary glands could also lead to
different levels of protein expression in the two parasite
species.
In the present study, several proteins belonging to the
glutathione S-transferase (GST) family were also upre-
gulated: GST S1, GST E1, GST D1 isoform D and GST
D1 isoform C. GST S1 and GST D1 isoform C wereTable 1 Upregulated proteins in P. falciparum-infected An. ga
Spot Accession number
(UniProtKB/TrEMBL)
Protein identification
666 P46428_ANOGA GST S1
Q9GPL9_ANOGA GST E1
685 P46428_ANOGA GST S1
695 Q93113_ANOGA GST D1 iso D
Q93112_ANOGA GST D1 iso C
927 Q93112_ANOGA GST D1 iso C
926 Q93112_ANOGA GST D1 iso C
919 Q7PWI1_ANOGA Ubiquinol cyt c reductase iron sulfur subu
794 Q9BIH5_ANOGA gSG6identified in several closed spots (Figure 2 and Table 1).
This could be due to post-translational modifications
such as glycosylation, phosphorylation and acetylation.
The GST proteins are strongly involved in diverse bio-
logical processes in almost organisms such as detoxifica-
tion of endogenous and xenobiotic compounds as well
as in protein transport and protection against oxidative
stress [75,76]. This protein family is conserved in the
majority of arthropods such as Ae. aegypti [77] and Cx.
quiquefasciatus [78]. The delta and epsilon classes of
GST are insect-specific [79]. The GST D1 isoform C and
D belongs to the delta class. These genes are rapidly di-
verging, suggesting a role in the adaptation of insects in
different ecological niches and may be involved in the
detoxification of environmental xenobiotics. This hy-
pothesis is supported by the implication of this delta
class in insecticide resistance [80]. GST E1 belongs to
the epsilon class implicated in the detoxification of in-
secticides and in the resistance to DDT [81-83]. They
also have peroxidase activity, which could be involved inmbiae salivary glands
Fold Molecular
mass (kDA)
pI Mascot score Sequence
coverage (%)
2.3 23.2 5.29 7 29.06
25.3 5.66 4 17.86
2.2 23.2 5.29 9 33.99
2.0 23.4 6.34 5 25.36
23.8 6.55 3 20.57
2.3 23.8 6.55 8 36.36
2.0 23.8 6.55 5 17.70
nit 2.0 28.1 8.53 3 9.43
1.8 13.1 5.49 14 45.22
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stress [84]. The GST S1 protein belongs to the sigma
class. This class of GST is found in indirect flight mus-
cles, suggesting a structural role. However, it could also
protect against the deleterious effects produced by oxi-
dative stress [76]. It has been shown that the malaria in-
fection in mosquito midguts induced an oxidative stress
producing reactive oxygen species [85]. Consequently,
the increase of GST family proteins probably counteracts
the negative effects induced by the infection.
For the other spots, the identification of up- or down-
regulated proteins was more complex. Numerous pro-
teins were identified in each spot, which did not allow
us to determine which proteins have their expression
modified (data not shown). Moreover, several proteins
were found both in up- and down-regulated spots, cer-
tainly due to post-translational modifications, which
made it impossible to conclude whether their expression
had been modulated. However, some identified proteins
in overexpressed spots involved in a glycolysis pathway
(triosephosphate isomerase, fructose biphosphate aldol-
ase, phosphoglycerate mutase and glyceraldehydes-3-
phosphate dehydrogenase) were also found upregulated
during DENV-3 infection in the cell line of Ae. albopic-
tus [86], DENV-2 or CHIKV-infected midgut of Ae.
aegypti [45] as well as in the P. berghei-infected head of
An. gambiae [61]. In addition, proteins involved in lipid
metabolism were found in overexpressed spots, in agree-
ment with a previous transcriptomic study [48]. All
these studies strengthen our hypothesis that these identi-
fied proteins are probably upregulated. Moreover, these
metabolic pathways are involved in energy production,
which is in accordance with the over-expression of the
ubiquinol-cytochrome c reductase iron-sulfur subunit. P.
falciparum infection seems to interfere with the meta-
bolic processes of An. gambiae salivary glands. This has
already been observed during the influenza virus [87]
and Leishmania [88] infection.
Surprisingly, only seven P. falciparum proteins were
found in over- and under-expressed spots (Additional
file 1). This result could be due to the protein extraction
protocol being insufficiently severe to disrupt sporozo-
ites. We can also assume that the amount of salivary
gland proteins was much greater resulting in a high sal-
ivary gland protein to parasite protein ratio, thus pre-
cluding the detection of the P. falciparum proteins.
Identification/selection of candidate biomarkers of
exposure to Anopheles infective bites
The selection of candidates as specific biomarkers for
infective bites was based on several criteria: i) over-
expression, i.e. overexpressed proteins or proteins found
in over-expressed spots with a high percentage of se-
quence coverage and a high number of identified peptides,suggesting that they are the major component of the spot;
ii) potential antigenicity, i.e. inferred from the presence of
a signal peptide in the protein sequence, meaning that they
are secreted in the saliva and injected into the human skin
during blood feeding and, as a consequence potentially in-
duce an Ab response in humans; and iii) the specificity of
proteins to the Anopheles genus. As the salivary protein
candidates are overexpressed, one hypothesis could be that
their antigenicity is increased, only after P. falciparum in-
fection, allowing the differentiation between infective and
non-infective bites. Among the overexpressed proteins
mentioned above, the ubiquinol-cytochrome c reductase
Rieske subunit and the GST proteins are common in many
organisms and are not secreted proteins. Consequently,
they are not suitable candidates for being a specific bio-
marker to Anopheles infected bites.
The gSG6 protein has been previously shown to be a
biomarker of exposure to Anopheles bites [17-20] and
some peptides have also been designed from this pro-
tein. Among them, gSG6-P1 and gSG6-P2 peptides were
antigenic, but only the gSG6-P1 peptide seemed posi-
tively associated with the level of human exposure to
Anopheles [21], in different exposure settings [22-25]. In
the present study, the expression of the gSG6 protein
was clearly increased in presence of wild P. falciparum.
This result suggests that this protein could also be a po-
tential candidate as a biomarker of infective bites. Recent
studies strengthen this point by demonstrating that the
Ab response to the gSG6 recombinant protein was asso-
ciated with malaria incidence in Tanzania [20] and that
the gSG6-P1 peptide could be an indicator of infection
risk during the dry season (very low exposure and trans-
mission) in northern Senegal [89].
Other candidate proteins as biomarkers were selected
from some over-expressed spots: gSG1b, TRIO protein,
long form D7 and SG5 (Figure 3 and Table 2). The gSG1b
and TRIO proteins have already been found to be overex-
pressed in P. berghei-infected salivary glands of An. gam-
biae [47]. This result supports the finding that, in the
present study, these proteins, identified among others in
overexpressed spots, seem clearly upregulated. The long
form D7 and SG5 proteins were selected, although their
sequences matched other arthropods but with a low iden-
tity. The long form D7 protein presented 35.1% identity
with Ae. Aegypti (e = 8e−51), 34.1% with Cx. quiquefascia-
tus (e = 5e−53), 31.3% with G. morsitans (e = 4e−04), and
27.3% with Phlebotomus papatasi (e = 2e−10) and Lutzomia
longipalpis (e = 3e−11). The SG5 presented 27.1% identity
with Ae. Aegypti (e = 1e-30) and 24.3% with Cx. quiquefas-
ciatus (e = 1e-34). The specificity of these proteins as bio-
markers of exposure to the Anopheles genus will have to
be verified and, for example, an animal model of exposure
could be used. The Ab response against these proteins, or
peptides derived from them, can be assessed in rabbits
Figure 3 Candidate proteins as biomarkers of Anopheles infective bites (2D-DIGE gel). Spots containing candidate proteins are indicated by
number. The pI and molecular weight scales are indicated in the figure.
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quefasciatus. However, the use of the peptides from these
proteins is another approach and an opportunity to de-
crease the possible immune cross-reactivity.
Peptide design and antigenicity of selected peptides as
potential candidate biomarkers
Aiming to optimize Anopheles specificity and to circum-
vent the limitations in the production of recombinant
protein and batch-to-batch variations, peptides from the
four previously selected proteins were designed (the
gSG1b, long form D7, SG5, TRIO proteins) so as to as-
sess their antigenic properties.
Bioinformatic tools were used to predict potential epi-
topes for each protein. The comparison of data generated
by the four algorithms defined two peptides for gSG1b
(gSG1b-P1 and gSG1b-P2), seven peptides for long form
D7 (D7-P1 to D7-P7), five peptides for SG5 (SG5-P1 to
SG5-P5) and two peptides for the TRIO protein (TRIO-P1
and TRIO-P2), 18–27 amino acid residues long (Table 3).Table 2 Identification/selection of candidate proteins as biom
Protein
identification
Accession number
(UniProtKB/TrEMBL)
Spot Fold Mascot
score
S
(
gSG6 SP Q9BIH5_ANOGA 794 1.8 14 4
gSG1b SP Q9BIH6_ANOGA 1197 1.6 59 4
Long form D7 SP Q7PJ76_ANOGA 1144 1.4 15 4
SG5 SP Q9BIH7_ANOGA 1228 2.0 15 2
1229 1.6 14 2
TRIO protein SP Q8WR22_ANOGA 819 1.4 12 3
1228 2.0 21 3
1229 1.6 15 2
1239 1.4 25 4
SP, signal peptide.All these peptides were aligned using the Blastp program
in Vectorbase to search for similarities with other he-
matophagous arthropods and the Blastp program in
UniProtKB to search for similarities with human infec-
tious organisms, to avoid immune cross-reactivity. No
relevant identity was found, as indicated by the low scores
observed (few amino acids (aa) consecutively matched and
high e-value, i.e., e > 0.03) (Table 4). This analysis showed
that all peptides selected possessed a high specificity for
the Anopheles species.
The antigenicity of these peptides was assessed using an
epitope-mapping approach, with serum from children
(n = 42) known to be exposed to Anopheles bites (Figure 4).
All peptides appeared to be antigenic, but different levels
of antigenicity between them were observed. The D7-P1,
SG5-P2, SG5-P3, SG5-P4, SG5-P5, TRIO-P1, TRIO-P2,
SG1b-P1 and SG1b-P2 peptides seemed to have a lower
antigenicity than the D7-P2, D7-P3, D7-P4, D7-P5, D7-P6,
D7-P7 and SG5-P1 peptides. A high antigenicity could be
one of the pertinent criteria for the identification ofarkers of Anopheles infective bites
equence coverage
%)
Peptide
number
Molecular mass
(kDA)
pI
5.22 14 13.1 5.49
6.23 59 43.6 7.58
0.19 15 35.6 5.90
9.22 15 38.2 6.47
9.52 14
1.46 12 43.7 6.46
6.83 21
9.41 15
0.15 25
Table 3 Peptide design of candidate proteins
Protein identification Accession number (UniProtKB/TrEMBL) Candidate peptide biomarker Peptide sequence
gSG6SP Q9BIH5_ANOGA gSG6-P1 EKVWVDRDNVYCGHLDCTRVATFK
gSG6-P2 ATFKGERFCTLCDTRHFCECKETREPL
Long form D7SP Q7PJ76_ANOGA D7-P1 FKALDPEEAWYVYERCHEDHLPS
D7-P2 DHLPSGPNRETYLKTWKFWK
D7-P3 GLQMYDEKTNTFKPETVPVQHEAYK
D7-P4 SRKIYHGTVDSVAKIYEAKPEIKKQ
D7-P5 NKSDLEPEVRSVLASCTGTQAYDYY
D7-P6 CTGTQAYDYYSCLLNSPVKEDFRN
D7-P7 GKVYEGPEKVKEELKKLNY
SG5SP Q9BIH7_ANOGA SG5-P1 GSLDPLDEEDIRTEQPTSCV
SG5-P2 VLVSIKSRMMAYTNDAVAKFEHL
SG5-P3 EECHDKLADHLAEQRREIDAAQ
SG5-P4 AEQRREIDAAQQLMGEPYRKMDG
SG5-P5 RRQLMKQNEREVVEKSKS
TRIO proteinSP Q8WR22_ANOGA TRIO-P1 PLTCIRWRSQNPASPAGSLGGKDVV
TRIO-P2 LGGKDVVSKIDAAMANFKTLF
gSG1bSP Q9BIH6_ANOGA gSG1b-P1 FEVCLPEIRKDPATAGLVTEV
gSG1b-P2 KKHMVASKDYESYLGALFAADA
SP, signal peptide.
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ant criterion is clearly that this biomarker can differentiate
Anopheles non-infective and infective bites. Moreover, the
level of the specific Ab response observed for each peptide
was, for instance, scattered ranging from 2136 to 7136
fluorescence/U.A. for D7-P6 peptide and from 223.5 to
2933.5 fluorescence/U.A. for TRIO-P1 peptide. We cannot
exclude that a history of human exposure to Anopheles
and the immune status of these individuals could greatly
contribute to the heterogeneity of the Ab response. The
next step of this work will be to evaluate the Ab response
to all these peptides on a large scale to compare theirTable 4 Sequence similarities of peptides with other hematop
Candidat peptide
biomarker
Identity (amino acid consecutive, e-value)
Culex
quinquefasciatus
Aedes
aegypti
Glossina
morsitans
Tri
va
D7-P1 4aa, e = 0.036 4aa, e = 0.3
D7-P2 4aa, e = 0.62
D7-P3 3aa, e = 0.13 6a
D7-P5 3aa, e = 0.23
D7-P6 3aa, e = 0.23 2aa, e = 0.046
D7-P7
SG5-P2
SG5-P4
SG5-P5antigenicity between individuals infected by P. falciparum
(individuals previously bitten by infected bites) and indi-
viduals exposed to Anopheles bites and identified as not
infected. However, the fold over-expression of these pro-
teins could also play a role in this differentiation. The up-
regulation of the selected proteins varies between 1.4 to
2.0 fold, and future studies are needed to evaluate whether
this over-expression is sufficient to differentiate infect-
ive and non-infective bites. Combination of different
overexpressed peptides (gSG6-P1, gSG6-P2, gSG1b-P1
and gSG1b-P2, D7-P1 to D7-P7, SG5-P1 to SG5-P5,
TRIO-P1 and TRIO-P2) could increase the specificity ofhagous arthropods or human infectious organisms
chomonas
ginalis
Leptospira
weilii
Cronobacter
sakazakii
Rhodnius
prolixus
Trypanosoma
cruzi
a, e = 3.1
6aa, e = 0.5
8aa, e = 6.7
3aa, e = 0.25
3aa, e = 9
Figure 4 IgG Ab response according to the different peptides. The IgG antibody level was evaluated in a sample of children living in
Senegal exposed to Anopheles bites. Box plots display the median value, 25th and 75th percentiles. Whiskers represent 5 to 95 percentiles and
dots the outliers.
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reduce the heterogeneity of Ab responses observed in
this study. Future immunological evaluation of these
peptides should be conducted using well documented
cohorts either for parasitological and immunological
status but also using entomological data to validate this
approach.
Conclusion
The present study has provided results on the effect of
the presence of the wild P. falciparum parasite on the
expression of proteins in An. gambiae salivary glands.
The parasite up- and down-regulates sialome expression,
but also seems to induce post-translational modifica-
tions. This study and further studies will provide key ele-
ments to understand how the insect cells act to protect
themselves against infection and how P. falciparum ma-
nipulates the cellular machinery of the salivary glands
and the behavior of Anopheles mosquitoes.
In this study, five salivary proteins – gSG6, gSG1b,
long form D7, SG5 and TRIO – were selected as poten-
tial candidate biomarkers of exposure to Anopheles in-
fective bites in order to evaluate the risk of malaria
transmission. Anopheles-specific and immunogenic pep-
tides were designed from these proteins in silico: gSG1b-
P1 and gSG1b-P2, D7-P1 to D7-P7, SG5-P1 to SG5-P5,
TRIO-P1 and TRIO-P2. Their immunogenicity was
tested and validated using blood from children exposed
to Anopheles bites. These results are the first step to-
ward the development of a biomarker of exposure to
Anopheles infective bites. This tool is essential to evalu-
ate the malaria transmission in areas of low transmission
such as urban settings, highlands and areas where theP. falciparum transmission has been tackled by malaria
control strategies. The next step will be to check whether
all these peptides, in addition to gSG6-P1 and gSG6-P2,
can differentiate An. gambiae-non-infective from -infective
bites.
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